A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

Hao Zhao1, Miao-Yan Zhang1, Kai-Ni Shen1

  • 1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Blood
|March 17, 2023
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos